These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31857847)

  • 1. Modulation of proliferation factors in lung adenocarcinoma with an analysis of the transcriptional consequences of genomic EGFR activation.
    Kucherlapati MH
    Oncotarget; 2019 Dec; 10(65):6913-6933. PubMed ID: 31857847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma.
    Ni L; Sun P; Fan X; Li Z; Ren H; Li J
    Front Pharmacol; 2021; 12():775514. PubMed ID: 35173608
    [No Abstract]   [Full Text] [Related]  

  • 3. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
    Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
    Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D; Luo L; Liang C
    PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
    Lu GS; Li M; Xu CX; Wang D
    Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes.
    Kucherlapati M
    BMC Cancer; 2018 Aug; 18(1):818. PubMed ID: 30107825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
    Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E
    Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X; Chen L; Zhang T
    Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
    Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
    Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZNF692 promotes proliferation and cell mobility in lung adenocarcinoma.
    Zhang Q; Zheng X; Sun Q; Shi R; Wang J; Zhu B; Xu L; Zhang G; Ren B
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1189-1196. PubMed ID: 28669730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analyses of differences between solid and nonsolid predominant lung adenocarcinomas.
    Luo J; Ma K; Shi Y; Chen Z; Zhao M; Huang Y; Wang S; Xi J; Zhan C; Xu S; Wang Q
    Thorac Cancer; 2018 Dec; 9(12):1656-1663. PubMed ID: 30276966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
    PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.
    Gan TQ; Chen WJ; Qin H; Huang SN; Yang LH; Fang YY; Pan LJ; Li ZY; Chen G
    Med Sci Monit; 2017 May; 23():2453-2464. PubMed ID: 28533502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic role of miR‑183‑5p in lung adenocarcinoma: A comprehensive study of qPCR, in vitro experiments and bioinformatic analysis.
    He RQ; Gao L; Ma J; Li ZY; Hu XH; Chen G
    Oncol Rep; 2018 Jul; 40(1):83-100. PubMed ID: 29749535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma.
    Liu C; Li Z; Wang S; Fan Y; Zhang S; Yang X; Hou K; Tong J; Hu X; Shi X; Wang X; Liu Y; Che X; Qu X
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):65-76. PubMed ID: 30357521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes.
    Tokar T; Pastrello C; Ramnarine VR; Zhu CQ; Craddock KJ; Pikor LA; Vucic EA; Vary S; Shepherd FA; Tsao MS; Lam WL; Jurisica I
    Oncotarget; 2018 Feb; 9(10):9137-9155. PubMed ID: 29507679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.
    Wang L; Zhao H; Xu Y; Li J; Deng C; Deng Y; Bai J; Li X; Xiao Y; Zhang Y
    Int J Cancer; 2019 Apr; 144(7):1723-1734. PubMed ID: 30226269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL; Gong Y; Zhao DP
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and prognosis effect of methylation-regulated SLIT3 and SPARCL1 genes in smoking-related lung adenocarcinoma].
    Wang J; Yu XF; Ouyang N; Zhao SY; Guan XF; Yao HP; Chen R; Chen T; Li JX
    Zhonghua Yi Xue Za Zhi; 2019 May; 99(20):1553-1557. PubMed ID: 31154721
    [No Abstract]   [Full Text] [Related]  

  • 20. USP4 expression independently predicts favorable survival in lung adenocarcinoma.
    Zhong M; Jiang Q; Jin R
    IUBMB Life; 2018 Jul; 70(7):670-677. PubMed ID: 29667299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.